Index
983
H
Haemodynamics, 696, 697–698
Haemolytic crisis, 169
Haemophilus B conjugate vaccine, 279
Haemophilus influenzae
B, 274, 279
Haemopohilia, 767
Haemoptysis, 681, 684
Haemorheologic agent, 751, 758, 767
Haemorrhagic disorders, 750, 754
Haemostatic agents, 750, 751, 767,
769–771
adverse effects, 770
care considerations, 770–771
contraindications and cautions, 770
drug–drug interactions, 770
pharmacokinetics, 769–770
systemic, 769–770
therapeutic actions and indications, 769
topical, 769–770
Hageman factor, 228, 231, 750, 753
Half-life, 15, 24–25
calculations, 24
Haloperidol, 200, 335–337, 345
Halothane, 422
Hamamelis water, 950
Hawthorn, 965
HDLs (high-density lipoproteins), 729,
732
Headaches.
See
Migraine headache
Healthcare pattern, 44
Heart block, 696, 699
Heart disease
anticholinergic drugs, 508–509
women and, 732
Heart failure, 652–653, 681, 682–685
cellular changes, 683
clinical manifestations, 683–684
compensatory mechanisms, 683
diuretic agents, using, 812–813
left-sided, 684
right-sided, 684
treatments, 684–685
Heart, structure and function, 643–646
automaticity, 642, 644–645
autonomic influences, 645–646
cardiac conduction, 644–646
cardiac cycle, 642, 643–644
conductivity, 642, 645
myocardial contraction, 646
Helminths, 179, 180
Helper T cells, 126, 134, 233
Heparin, 751, 752, 754, 756, 759–760,
762–764
low-molecular-weight, 751, 757, 766
overdose, 763
Hepatic enzyme system, 23
drugs that alter, 23
Hepatic microsomal system, 15, 23
Hepatitis A, 274
vaccine, inactivated, 280
hepatitis B recombinant vaccine,
with, 280
Hepatitis B, 126, 274
drugs for, 144–146
vaccine, 280
Hepatitis B immune globulin, 286
Hepatitis C
drugs for, 144–146
Hepatoxicity, 36
Herbal medicine, 63–64
alternative therapies.
See
Alternative
and complementary therapies
ephedra, 459
Heroin, 67
Herpes and cytomegalovirus, 126, 132
agents for, 127, 132–134
adverse effects, 133
care considerations, 134
contraindications and cautions, 133
drug–drug interactions, 133–134
pharmacokinetics, 133
therapeutic actions and indications,
132
cytomegalovirus immunoglobulin, 286
Hexachlorphene, 950
Hexamine hippurate, 821
Hiccoughs, intractable, 929, 932
High-ceiling diuretics, 803, 809
High-density lipoproteins (HDLs), 729,
732
Hindbrain, 292, 298
Hirsuitism, 627, 630
Histamine, 231–232
Histamine-2 antagonists, 896, 897,
899–904
adverse effects, 901, 903
care considerations, 903–904
contraindications and cautions, 901
critical thinking scenario, 902–903
drug–drug interactions, 903
pharmacokinetics, 901
therapeutic actions and indications,
897, 901
Histamine-2 receptors, 888, 891
Histocompability antigens, 72, 74
HIV and AIDS, 126, 128
agents for, 127, 134–144
care considerations, 142
CCR5 coreceptor antagonist, 126, 136,
141
critical thinking scenario, 143–144
education, 138
fixed combination drugs, 139
fusion inhibitor, 126, 136, 140
integrase inhibitor, 126, 136, 141–142
non-nucleoside reverse transcriptase
inhibitors, 126, 135, 136
adverse effects, 135
contraindications and cautions, 135
drug–drug interactions, 135
pharmacokinetics, 135
therapeutic actions and indications,
135
nucleoside reverse transcriptase
inhibitors, 126, 135–139
adverse effects, 138
contraindications and cautions,
137–138
drug–drug interactions, 138–139
pharmacokinetics, 137
therapeutic actions and indications,
137
protease inhibitors, 126, 139–140
adverse effects, 140
contraindications and cautions,
139–140
drug–drug interactions, 140
pharmacokinetics, 139
therapeutic actions and indications,
139
Hives, 33–34
HMG-CoA reductase inhibitors,
737–738, 740–743
adverse effects, 741
care considerations, 741–742
contraindications and cautions, 741
drug–drug interactions, 741
hydroxymethylglutaryl-coenzyme A
(HMG-CoA), 729, 733
pharmacokinetics, 741
therapeutic actions and indication, 740
Homatropine, 957
Home care, 65
Hookworm infections, 180, 181
hookworms, 179
Hop, 965
Horehound, 965
Hormone modulators, 191, 212–216,
513–514
adverse effects, 215
care considerations, 216
contraindications and cautions, 212
drug–drug interactions, 215
pharmacokinetics, 212
releasing hormones or factors, 514
therapeutic actions and indications, 212
Hormone replacement therapy (HRT),
612–613
Hormones, 512, 513
inhibiting, 516
stimulating, 516
Horse chestnut seed, 965
Human fibrin sealant, 767, 769
Human immune response, 83–84
Human papillomavirus (HPV), 274
recombinant, quadrivalent, 280
Human sexual response, 603–604
Hyaluronidase derivatives, 253–254
Hydantoins, 356–358
adverse effects, 358
contraindications and cautions, 358
drug–drug interactions, 358
pharmacokinetics, 356
therapeutic actions and indications,
356
Hydralazine, 666, 674
Hydrochloric acid, 888, 891
Hydrochlorothiazide, 675, 803, 805–808
Hydrocodone, 401
Hydrocortisone, 539, 542, 543, 543, 547,
954, 957
Hydromorphone, 402
Hydrostatic pressure, 650
Hydroxocobalamin, 775, 787, 788
Hydroxychloroquine, 163, 166–167, 169
Hydroxymethylglutaryl-coenzyme A
(HMG-CoA).
See
HMG-CoA
reductase inhibitors
